average weight loss on glp 1 Hidden Risks of GLP-1 Inhibitors: Muscle and "Ozempic Face" GLP-1 Medications for Weight Loss:

Messaging that Matters: Clarity, Context, and Credibility As public interest in weight-loss drugs skyrockets, marketers must avoid sensationalism

About this article Cite this article Gourdy, P., Darmon, P., Dievart, F

Although this does not indicate direct senolytic activity, it is consistent with a model in which improved mitochondrial function and nutrient signaling reduce the upstream conditions that promote senescence

The growing trend of off-label use in weight management among non-diabetic individuals is further expanding the market base, creating unprecedented momentum for this therapeutic class

L.ZhongW.ShuJ.Abu MuchA.LotanD.GrupperA.et al (2021)

Translation: There is absolutely no conclusive scientific evidence to support any of these claims, says Gans, meaning its hard to tell whether or not the plan will actually work for you